Ira Gotliv

Dr. Ira Gotliv is VP of Pre-Clinical Research at Emendo. In this role, Ira oversees the Pre-Clinical Research department which is responsible for evaluation and early development of potential products in multiple indications. Ira has 8 years of experience in the Pharma and Medical device industries in leading positions. Ira has extensive knowledge in cell biology and biochemistry with more than 16 years of experience in research. Prior to joining Emendo, Ira was a Preclinical Manager at Nano-Ghost, responsible for the preclinical development of an MSC-derived delivery platform for oncology indications, as well as Associate Director at Pi-Therapeutics, where she was responsible for developing a small molecule for treatment of Hematological malignancies from early discovery to pre-IND submission. Ira holds a Ph.D. and a Post Doc. in Biological Chemistry from the Weizmann Institute of Science, Israel.